Development of a hyaluronan bioconjugate for the topical treatment of melanoma.
Zhang
Li-Shu
LS
Greyner
Henry J
HJ
Mummert
Mark E
ME
Petroll
W Matthew
WM
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage*; D045744:Cell Line, Tumor; D004317:Doxorubicin / Q000008:administration & dosage*; D016503:Drug Delivery Systems; D006801:Humans; D018960:Hyaluronan Receptors / Q000096:biosynthesis; D006820:Hyaluronic Acid / Q000008:administration & dosage*; D015603:Keratinocytes / Q000187:drug effects; D008546:Melanoma, Experimental / Q000188:drug therapy*; D051379:Mice; D008810:Mice, Inbred C57BL; D012867:Skin / Q000187:drug effects; D012878:Skin Neoplasms / Q000188:drug therapy*
D000903:Antibiotics, Antineoplastic; D018960:Hyaluronan Receptors; D004317:Doxorubicin; D006820:Hyaluronic Acid